Conference Coverage: ASH 2025 – Focus on NHL and CLL
Lymphoma-specific discussions on the latest research updates, therapeutic advances, and their application in clinical decision-making
December 16, 2025
FACULTY CHAIR
Brad Kahl, MD
Washington University School of Medicine, St Louis, MO, USA
FACULTY MEMBERS
Pier Luigi Zinzani, MD, PhD
University of Bologna Institute of Hematology and Medical Oncology, Italy
Georg Hess, MD
Johannes Gutenberg University Mainz, Germany
John Gribben, MD, DSc, FRCP, FRCPath, FMedSci
Barts Cancer Institute, London, UK
Paolo Caimi, MD
Cleveland Clinic, Cleveland, OH, USA
Matthew Lunning, DO, FACP
University of Nebraska Medical Center, Omaha, NE, USA
KEY TAKEAWAYS
- Advances in DLBCL/Aggressive B-Cell Lymphoma
- DLBCL — Novel Regimens
- Advances in Follicular Lymphoma
- Mantel Cell Lymphoma
- Evolving Therapies in CLL/SLL
- Hodgkin Lymphoma
